Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

LegalView Updated its Traumatic Brain Injury Blog with Results of Brain Injury Victim Critical Care Study

(EMAILWIRE.COM, June 16, 2008 ) Denver, CO - LegalView.com, the number one resource for everything legal on the Internet, provided resources for readers of the traumatic brain injury (TBI) blog via its revamped TBI information portal. The information includes several groundbreaking surveys in which critical care providers of TBI patients were interviewed to improve on the guidelines for brain injury treatment (http://brain-injury.legalview.com/brain-injury-treatment.aspx). The first study, conducted in 1995 by researchers at Cornell University Medical College, monitored the treatment of severe head injury patients and then collected data via telephone interviews with nurse managers, clinical specialists and staff nurses. The results uncovered a wide variation of guidelines for managing head injury victims. It is important for the medical community to strive for perfection with the use of guidelines among patient treatments, without guidelines, it is near impossible to regulate treatment methods.

Individuals who have been involved in a TBI accident are advised to speak with a brain injury lawyer(http://brain-injury.legalview.com/brain-injury-lawyer.aspx) about the potential for developing a brain injury case (http://brain-injury.legalview.com/brain-injury-case.aspx). Often, medical bills associated with a head injury can quickly add up and looking into a brain injury lawsuit (http://brain-injury.legalview.com/brain-injury-lawsuit.aspx) may lead to monetary compensation as a potential outcome, which would help a victim suffering from a brain injury.

The study conducted in 2006 and published in The Journal of Trauma Injury, Infection, and Critical Care picked up where the 1995 and 2000 studies left off. The study reported dramatic improvements in the guidelines for caring for and treating TBI patients. Additionally, the study compared the morality rates of patients before the implementation of the TBI care guidelines and found a marked reduction in deaths among patients. Although the study found improvements in the state of health care for brain injury victims, it is often recommended that contacting an experienced brain injury law firm (http://brain-injury.legalview.com/brain-injury-law-firm.aspx) is a good preventative measure as a brain injury attorney (http://brain-injury.legalview.com/brain-injury-attorney.aspx) can provide insight into the legalities surrounding a brain injury victim's injury to ensure they are protected. To learn more about locating brain injury lawyers (http://brain-injury.legalview.com/brain-injury-lawyers.aspx) in a specific area, visit http://brain-injury.legalview.com/.

For other areas of legal issues, use the LegalView homepage and peruse an extensive library of topics ranging from pharmaceutical drugs to rare disorders and conditions to accidents. Currently, LegalView has maintained its status as the top legal resource information provider for victims of controversial pharmaceutical drugs by continually updating news on topics like the Chantix side effects, the Levaquin risks and the Digitek digoxin recall.

Chantix, a prescription drug for individuals trying to quit smoking, was allegedly linked to several hundred reports of suicidal thoughts and tendencies, depression and erratic behavior among individuals taking the drug. The Chantix side effects (http://chantix.legalview.com), while currently being investigated, have not sparked a recall even after 38 suicides were reported among patients who were allegedly taking the smoking cessation drug.

The Levaquin risks (http://levaquin.legalview.com) that have surfaced in recent months derive from a study published in the Journal of the American Board of Family Medicine in the September-October 2003 issue that found the drug, which treats an array of infections from pneumonia to bronchitis, may cause an increase in tendon ruptures for patients. While reports of the alleged side effects come to light, officials are proceeding with a campaign to release a child-version of the infection-fighting drug.

The most recent news regarding the Digitek recall (http://Digitek-digoxin.legalview.com) is also available through LegalView's information portal, with information on the alleged manufacturing defect that caused the heart congestive failure drug to contain double the amount of appropriate doses, leaving patients exposed to potentially toxic levels of the drug.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.


LegalView
Katie Kelley
720-226-6613
press-releases@legalview.com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC